Recombinant Mouse TMEM225 is a partial-length protein (UniProt ID: Q9D9S2) expressed in Escherichia coli using codon-optimized DNA sequences. Key production details include:
| Parameter | Specification |
|---|---|
| Product Code | CSB-EP023820MO1 |
| Expression System | E. coli |
| Purity | >85% (verified by SDS-PAGE) |
| Storage | Lyophilized form: 12 months at -20°C/-80°C; reconstituted: 6 months at -20°C/-80°C |
| Reconstitution | Deionized sterile water (0.1–1.0 mg/mL), with optional 50% glycerol for stability |
This recombinant protein lacks post-translational modifications and is primarily used in antibody generation, protein interaction studies, and functional assays .
Studies using Tmem225 knockout (KO) mice revealed its critical role in sperm maturation and fertility:
KO sperm showed dysregulation in pathways critical for sperm function:
| Pathway | Impact |
|---|---|
| Glycolysis | Reduced ATP production, affecting motility |
| Mitochondrial Function | Impaired oxidative phosphorylation and ROS scavenging |
| Flagellar Morphology | Disrupted axonemal structure and bending capacity |
These defects suggest TMEM225 regulates protein trafficking or stability during sperm maturation .
Recombinant TMEM225 facilitates:
Antibody Development: Used to generate antibodies for detecting endogenous TMEM225 in testicular tissues .
Mechanistic Studies: Investigating its interaction with protein phosphatase 1 (PP1) via PPP1CC binding, which modulates sperm capacitation .
Diagnostic Tools: Evaluating TMEM225 expression in urinary cell pellets as a biomarker for bladder cancer .
Current research gaps include:
TMEM225 is a four-transmembrane domain protein containing an RVxF motif, which serves as a consensus binding site for serine/threonine protein phosphatase 1 (PP1). The protein is encoded by the Tmem225 gene with an open reading frame of approximately 696 bp. In mice, TMEM225 is a testis-specific protein that plays a critical role in male fertility. The protein structure includes four putative transmembrane helices, with the carboxy-terminal region being particularly important for its interaction with PP1γ2 .
TMEM225 expression is highly specific to testicular germ cells, with expression levels increasing during spermatogenesis. The protein is not detected in other tissues, making it a truly testis-specific protein. In mature spermatozoa, TMEM225 is precisely localized to the equatorial segment of the acrosome but is absent from the midpiece and tail regions. Following the acrosome reaction, TMEM225 is lost from the dorsal region of the acrosome . In situ hybridization studies have shown that TMEM225 mRNA is primarily expressed in spermatocyte cells and round spermatids .
TMEM225 expression shows age-related specificity in the testis. In rats, significant expression has been observed specifically during the adult period after 13 months of age. This temporal expression pattern suggests that TMEM225 may be more important for sperm maturation and function rather than initial spermatogenesis. Interestingly, research has indicated that the expression phase is not related to the first wave of spermatozoon development, which has led to suggestions that TMEM225 may play an important role in sperm maturation processes rather than early spermatogenesis .
TMEM225 is essential for sperm maturation and male fertility. Knockout studies have revealed that male mice lacking TMEM225 are infertile. Importantly, while Tmem225 deletion does not affect spermatogenesis itself, TMEM225-null sperm exhibit significant abnormalities during epididymal maturation. These abnormalities include reduced sperm motility, abnormal hairpin-loop configuration, elevated reactive oxygen species (ROS) levels, and flagellar folding, collectively manifesting as asthenospermia (poor sperm motility). These findings indicate that TMEM225 controls critical aspects of the sperm maturation process, particularly in the epididymis .
TMEM225 contains an RVxF motif, which is a consensus site for interaction with serine/threonine protein phosphatase 1 (PP1). Biochemical studies have confirmed that TMEM225 interacts with PP1 in vivo. Pull-down assays have specifically demonstrated that the carboxy-terminal region of TMEM225 can bind to PP1γ2, which is the predominant isoform of PP1 in male germ cells. Furthermore, TMEM225 inhibits PP1γ2 activity in vitro through its RVxF motif. This regulatory role suggests that TMEM225 modulates sperm differentiation and function by regulating PP1γ2 activity, which is known to be necessary for normal spermatogenesis as well as spermatozoa capacitation and motility .
Proteomic analyses of cauda sperm from TMEM225 knockout mice have revealed several dysregulated pathways:
Mitochondrial function pathways: Impaired energy production affecting sperm motility
Glycolytic pathways: Altered energy metabolism critical for sperm function
Sperm flagellar morphology pathways: Leading to structural abnormalities in sperm flagella
These molecular alterations collectively contribute to the observed high reactive oxygen species levels, reduced motility, and flagellar folding that characterize TMEM225-null sperm. The data suggest that testicular TMEM225 controls sperm maturation by regulating the expression of proteins involved in these critical pathways during epididymal transit and maturation .
Based on published research protocols, the recommended approach for generating TMEM225 antibodies involves:
Peptide selection: Design antibodies against the carboxy-terminal region of mouse TMEM225. The sequence 217NRPHTQARRVTWAL230 has been successfully used in previous studies.
Conjugation method: Conjugate the selected peptide to keyhole limpet hemocyanin (KLH).
Immunization protocol: Raise rabbit polyclonal antibodies against the KLH-conjugated peptide following standard immunization schedules.
Validation tests:
This approach ensures generation of specific antibodies that can reliably detect TMEM225 in various experimental contexts.
Multiple complementary techniques should be employed for accurate localization studies:
Immunofluorescence microscopy: Offers high-resolution imaging of TMEM225 distribution in fixed sperm. Critical controls include TMEM225 knockout samples and peptide pre-absorption controls.
Subcellular fractionation followed by Western blotting: Allows biochemical verification of TMEM225 presence in specific cellular compartments (e.g., membrane fractions).
Immunoelectron microscopy: Provides ultrastructural localization, particularly important for resolving TMEM225's precise distribution within the complex acrosomal region.
GFP fusion protein expression: Complementary approach to validate localization patterns observed with antibody-based methods.
Studies have demonstrated that TMEM225 localizes to the equatorial segment of the acrosome in mature spermatozoa but is absent from the midpiece and tail. Additionally, GFP localization analysis in rats has shown that TMEM225 primarily surrounds the nuclear membrane, with some distribution in the cytoplasm .
Based on successful previous studies, researchers should consider:
Targeting strategy:
Design targeting constructs to disrupt critical exons encoding transmembrane domains
Consider conditional knockout approaches if complete knockout causes infertility
Verification methods:
PCR genotyping with specific primers for wild-type and mutant alleles
RT-PCR and Western blotting to confirm absence of TMEM225 mRNA and protein
Immunohistochemistry to verify protein absence in testicular sections
Housing conditions:
Maintain mice under specific pathogen-free conditions at controlled temperature (22 ± 1°C)
Expose to constant 12-h light-dark cycle as used in published studies
Phenotypic analysis focus:
For optimal proteomic analysis of TMEM225-dependent sperm protein changes, researchers should consider:
Sample preparation:
Carefully isolate cauda epididymal sperm using swim-up methods to ensure purity
Employ stringent washing steps to remove epididymal fluid contaminants
Use appropriate protease inhibitors to prevent degradation
Mass spectrometry approach:
Implement Orbitrap Q Exactive HF mass spectrometer or similar high-resolution instruments
Use these recommended parameters:
MS1: Resolution 60,000, scan range 350-1600 m/z, AGC 3e6, maximum injection time 50 ms
MS2: Resolution 30,000, charge state screening (+2 to +7 charges), dynamic elimination for 90 s
Collision energy: 30%
Comparative analysis strategy:
This approach has successfully identified functional pathways disrupted in TMEM225-null sperm, providing mechanistic insights into the observed asthenospermia phenotype.
Some studies suggest TMEM225 may play a role in sperm degeneration rather than spermatogenesis , while others indicate it's essential for sperm maturation during epididymal transit . To resolve these seemingly contradictory findings, researchers should:
Temporal expression profiling:
Conduct detailed age-dependent expression analysis from prepuberty through advanced age
Use RNA-seq and protein quantification at multiple developmental timepoints
Compare expression patterns across different species (mouse, rat, human)
Conditional knockout approaches:
Generate stage-specific conditional knockout models using spermatogonia-, spermatocyte-, or spermatid-specific Cre lines
Compare phenotypes between these models to pinpoint the critical stage requiring TMEM225
Functional rescue experiments:
Attempt rescue of TMEM225 knockout phenotypes by expressing TMEM225 at different developmental stages
Create chimeric proteins to identify which domains are essential for specific functions
Cross-species comparative studies:
Detailed comparative analysis between mouse, rat, and human TMEM225 function
Investigate whether age-dependent effects differ between species
These approaches can help distinguish between primary effects on spermatogenesis versus secondary effects on sperm maturation and clarify the seemingly contradictory findings in the literature.
To thoroughly investigate TMEM225's role in regulating ROS and mitochondrial function:
ROS measurement techniques:
Flow cytometry with specific ROS indicators (H₂DCFDA, MitoSOX Red, CellROX)
Luminol-based chemiluminescence assays for quantitative comparison
Live-cell imaging of ROS dynamics in wild-type versus knockout sperm
Mitochondrial function assessment:
Seahorse XF analyzer to measure oxygen consumption rate (OCR) and extracellular acidification rate (ECAR)
JC-1 staining to evaluate mitochondrial membrane potential
Targeted metabolomics focusing on TCA cycle intermediates and related metabolites
Mechanistic studies:
Evaluate key antioxidant enzymes (SOD, catalase, GPx) at protein and activity levels
Assess electron transport chain complex activities in isolated sperm mitochondria
Measure ATP production in wild-type versus TMEM225-null sperm under different metabolic conditions
Intervention studies:
Test whether antioxidant supplementation can rescue TMEM225 knockout phenotypes
Evaluate whether mitochondria-targeted antioxidants show greater efficacy than general antioxidants
Investigate if bypassing affected energy production pathways can restore sperm function
These approaches would provide comprehensive insights into how TMEM225 regulates mitochondrial function and ROS production, which appear to be critical mechanisms underlying the observed sperm dysfunction in knockout models .
The relevance of mouse TMEM225 research to human fertility is supported by several observations:
Expression conservation: TMEM225 shows testis-specific expression in both mice and humans, suggesting conserved function.
Clinical correlations: Abnormal TMEM225 expression levels have been found in patients with nonobstructive azoospermia, indicating potential clinical relevance.
Phenotypic similarity: The asthenospermia phenotype observed in TMEM225 knockout mice mirrors certain forms of human male infertility.
Molecular pathway conservation: The pathways affected by TMEM225 deficiency (mitochondrial function, glycolysis, flagellar morphology) are all implicated in human male infertility cases.
Researchers investigating potential translational applications should consider:
Genetic screening for TMEM225 mutations in infertile men, particularly those with asthenospermia
Evaluating TMEM225 protein levels in human sperm samples as a potential biomarker
Exploring whether TMEM225 function could be targeted pharmaceutically to address specific forms of male infertility
For effective cross-species comparison, researchers should:
Gene sequence analysis:
Conduct detailed sequence alignment and phylogenetic analysis
Identify conserved domains, particularly transmembrane regions and the PP1-binding motif
Calculate sequence homology percentages between species
Expression pattern comparison:
Use RNA-seq data from multiple species to compare tissue specificity
Employ cross-reactive antibodies (or species-specific antibodies) for Western blot and immunohistochemistry
Compare developmental timing of expression onset across species
Functional conservation assessment:
Test whether human TMEM225 can rescue mouse knockout phenotypes
Evaluate PP1 binding capabilities across species
Compare subcellular localization patterns in sperm from different species
Structural biology approaches:
Generate structural models of TMEM225 from different species
Compare predicted protein-protein interaction interfaces
Evaluate conservation of post-translational modification sites
These comparative approaches can help determine which aspects of TMEM225 function are evolutionarily conserved and therefore most likely to be relevant to human reproductive biology .
Working with recombinant transmembrane proteins like TMEM225 presents several challenges:
Expression system selection:
Challenge: Transmembrane proteins often express poorly in bacterial systems
Solution: Use mammalian expression systems (HEK293, CHO cells) or insect cell systems (Sf9, High Five) that better handle membrane proteins
Recommendation: For TMEM225, mammalian systems most closely recapitulate native folding
Protein solubilization and purification:
Challenge: Membrane proteins require detergents that can affect structure/function
Solution: Screen multiple detergents (DDM, CHAPS, LMNG) at varying concentrations
Alternative approach: Consider nanodiscs or amphipols for a more native-like environment
Functional assay development:
Challenge: Assessing PP1γ2 inhibition activity in purified systems
Solution: Establish in vitro phosphatase assays using purified PP1γ2 and appropriate substrates
Control: Include RVxF motif peptides as competitive inhibitors to validate specificity
Structural integrity verification:
Challenge: Confirming proper folding of recombinant TMEM225
Solution: Circular dichroism to assess secondary structure content
Advanced approach: Consider limited proteolysis coupled with mass spectrometry to verify structural domains
These strategies can help overcome the inherent difficulties in working with recombinant transmembrane proteins like TMEM225, facilitating more reliable functional and structural studies .
To comprehensively evaluate TMEM225's impact on sperm function:
Computer-assisted sperm analysis (CASA):
Use standardized parameters for motility assessment (total motility, progressive motility, curvilinear velocity, straight-line velocity, amplitude of lateral head displacement)
Compare wild-type, heterozygous, and homozygous knockout sperm under identical conditions
Record multiple fields and time points to capture the full range of motility patterns
Capacitation assessment:
Monitor tyrosine phosphorylation patterns during capacitation
Evaluate hyperactivated motility development
Assess calcium influx patterns using fluorescent indicators
Acrosome reaction quantification:
Use multiple complementary methods (Coomassie blue staining, PNA lectin binding, anti-acrosomal antibodies)
Induce acrosome reaction with physiological (ZP proteins) and non-physiological (calcium ionophore) stimuli
Time-course studies to detect potential differences in reaction kinetics
Sperm-egg interaction assays:
Zona-binding assays with wild-type versus TMEM225-null sperm
Fertilization rate comparison using in vitro fertilization
Assessment of post-fertilization events (if fertilization occurs)